Quantification of the Risk of Corticosteroid-induced Diabetes Mellitus Among the Elderly.
about
Steroid hyperglycemia: Prevalence, early detection and therapeutic recommendations: A narrative reviewGlucose intolerance and diabetes mellitus in ulcerative colitis: pathogenetic and therapeutic implicationsChronic obstructive pulmonary disease treated with inhaled medium- or high-dose corticosteroids: a prospective and randomized study focusing on clinical efficacy and the risk of pneumonia.Quantifying the real life risk profile of inhaled corticosteroids in COPD by record linkage analysisAllergic diseases in the elderlyGlucocorticoid treatment and impaired mood, memory and metabolism in people with diabetes: the Edinburgh Type 2 Diabetes Study.Monitoring of patients on long-term glucocorticoid therapy: a population-based cohort studyGlucocorticoid Excess Increases Hepatic 11β-HSD-1 Activity in Humans: Implications in Steroid-Induced Diabetes.Inhaled Corticosteroids Use Is Not Associated With an Increased Risk of Pregnancy-Induced Hypertension and Gestational Diabetes Mellitus: Two Nested Case-Control StudiesComorbid diabetes and COPD: impact of corticosteroid use on diabetes complications.Cardiovascular, rheumatologic, and pharmacologic predictors of stroke in patients with rheumatoid arthritis: a nested, case-control study.Rheumatoid arthritis in the elderly in the era of tight control.Elderly-onset sarcoidosis: prevalence, clinical course, and treatment.Systemic glucocorticoid therapy: a review of its metabolic and cardiovascular adverse events.Can side effects of steroid treatments be minimized by the temporal aspects of delivery method?Optimizing the Treatment of Steroid-Induced Hyperglycemia.Management of Inflammatory Bowel Disease in the Elderly Patient: Challenges and Opportunities.Glucocorticoid-Induced Diabetes Mellitus: An Important but Overlooked Problem.Age Disparities in the Use of Steroid-sparing Therapy for Inflammatory Bowel Disease.Decisional support to prevent adverse drug reactions of long latency: pilot randomized controlled intervention for glucocorticoid-induced diabetes.Diabetes risks and outcomes in chronic obstructive pulmonary disease patients: Two nationwide population-based retrospective cohort studies.Exploring the association between atypical neuroleptic agents and diabetes mellitus in older adults.The influence of hyperglycemia and other clinical variables on rehabilitation and hospital length of stay after neurosurgery in patients with cancer.Concomitant Medication Use and New-Onset Diabetes Among Medicaid Beneficiaries with Chronic Obstructive Pulmonary Disease.Sudden sensorineural hearing loss: systemic steroid therapy and the risk of glucocorticoid-induced hyperglycemia.Steroid-induced impairment of glucose tolerance: Prevalence among pediatric patients on long-term steroid use in Nigeria.Acetylsalicylic acid-tris-hydroxymethyl-aminomethane reduces colon mucosal damage without causing gastric side effects in a rat model of colitis.
P2860
Q26799242-972B1C5E-CED4-4A0A-AB21-793087D7DBC7Q26866110-3A0287E8-659A-44D9-81F4-5A014C30D8B8Q33709357-00C328BB-F6CD-4EC9-B008-537C7BF6C782Q34551086-076F030B-C4AC-417D-8C6F-A21C4FC0262FQ35919934-DC6E6C36-7169-436A-B31D-092E4984C165Q35926504-777D8371-98D1-4B0F-9F26-DBD3D0A8C341Q36151251-62EB8113-F280-4DF7-836C-79F339E99880Q36433592-22A0D8D2-1021-4113-8C43-B81A6A60ABD1Q36988673-D1C5F347-06FD-4367-B8FC-C618F1A69D4AQ37193551-F1236DC9-71F0-476C-903C-087CBD116F50Q37422931-02097F77-066E-4B81-ABD6-18CE9DC84EDCQ38150731-5F96A981-1088-47E4-94AF-73BD22AEFBCCQ38160360-26236FF0-17F0-4432-B714-B66DC779E1A5Q38247488-A78C9628-1A60-4EAF-A3EC-E71F914F1232Q38254723-270C2526-2F11-44B2-942E-5747480628A0Q38610756-965C16D9-44C5-416E-BFB3-B7838E128CB8Q38735146-2758F31C-5CBD-4A05-B0B4-401243643701Q39337363-3321A0FE-C677-4B4E-BB4D-2C8985A60A1CQ39602367-14D76A08-336D-42B5-920D-5FA7AF637F36Q41104118-1228B310-C8FC-4A00-9666-EF0314F4101FQ41432972-FC7158B3-4DBF-4D3B-95A5-8B65A0B360C2Q44657170-6B86F1E7-9904-4858-BF90-22908782A76FQ44923619-A7BE9CC2-0FAA-4545-A8F9-7D2A8E3E2705Q45043975-7FB3FB06-7D3B-4AC5-9868-DD81F5720D09Q45097546-C3F5C855-98B2-445D-B466-1C58F23F1002Q46800535-FA6B314A-ECCC-491D-AD2F-E97DEF31CE96Q47908307-86EBA5E9-94FE-4590-8A41-8EA6E24FFB96
P2860
Quantification of the Risk of Corticosteroid-induced Diabetes Mellitus Among the Elderly.
description
2002 nî lūn-bûn
@nan
2002 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
Quantification of the Risk of Corticosteroid-induced Diabetes Mellitus Among the Elderly.
@ast
Quantification of the Risk of Corticosteroid-induced Diabetes Mellitus Among the Elderly.
@en
Quantification of the Risk of Corticosteroid-induced Diabetes Mellitus Among the Elderly.
@nl
type
label
Quantification of the Risk of Corticosteroid-induced Diabetes Mellitus Among the Elderly.
@ast
Quantification of the Risk of Corticosteroid-induced Diabetes Mellitus Among the Elderly.
@en
Quantification of the Risk of Corticosteroid-induced Diabetes Mellitus Among the Elderly.
@nl
prefLabel
Quantification of the Risk of Corticosteroid-induced Diabetes Mellitus Among the Elderly.
@ast
Quantification of the Risk of Corticosteroid-induced Diabetes Mellitus Among the Elderly.
@en
Quantification of the Risk of Corticosteroid-induced Diabetes Mellitus Among the Elderly.
@nl
P2093
P2860
P1476
Quantification of the Risk of Corticosteroid-induced Diabetes Mellitus Among the Elderly.
@en
P2093
David Blackburn
Muhammad Mamdani
P2860
P304
P356
10.1046/J.1525-1497.2002.10649.X
P577
2002-09-01T00:00:00Z
P5875
P6179
1005617075